ReviewAdvances in experimental medicine and biology2026
Protein Architecture and Composition in Mycobacterium tuberculosis.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- EP9158H: An Immunoinformatics-Designed mRNA Vaccine Encoding Multi-Epitope Antigens and Dual TLR Agonists for Tuberculosis Prevention.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The protein architecture of Mycobacterium tuberculosis (Mtb) demonstrates remarkable complexity and adaptability, emblematic of its evolutionary refinement as a highly successful pathogen. The Mtb proteome can be broadly classified into four principal categories: core, accessory, transcriptionally plastic, and uncharacterized proteins. Core proteins are highly conserved across all Mtb strains and essential for fundamental cellular functions and bacterial viability; they form the structural and metabolic foundation required for critical processes such as DNA replication, transcription, and cell wall biosynthesis. Conversely, accessory proteins exhibit considerable variability among strains, endowing Mtb with strain-specific traits including virulence, environmental adaptation, and antibiotic resistance. These proteins are vital for enabling the pathogen to thrive in diverse ecological niches and to overcome selective pressures imposed by environmental factors and antimicrobial agents. Distinguished not by strain distribution but by regulatory dynamics, transcriptionally plastic proteins exhibit differential expression in response to environmental changes and host-derived cues, allowing Mtb to modulate its physiological state during infection rapidly. This regulatory flexibility supports the pathogen's ability to enter dormancy, mount stress responses, and transition between metabolic states. A substantial portion of the Mtb proteome remains uncharacterized or annotated as hypothetical, with functions yet to be elucidated. Nevertheless, recent advances in integrative bioinformatics and experimental proteomics have begun to clarify the roles of many such proteins, revealing novel contributions to bacterial survival, pathogenicity, and immune evasion. The complex interplay among these protein categories illustrates a highly sophisticated regulatory network that governs Mtb's growth, dormancy, stress adaptation, and persistence. This dynamic and adaptable protein architecture is fundamental to the bacterium's capacity to endure hostile host environments, evade immune surveillance, and establish chronic infections. Consequently, a comprehensive understanding of the composition, regulation, and functional plasticity of these protein classes is imperative. Such knowledge will drive the development of innovative diagnostics, next-generation vaccines, and targeted therapeutics, ultimately advancing more effective strategies for tuberculosis control and eradication.
Indexed as
Identifiers
41207937What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.